(Q43673452)

25 November 2017

Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan (English)

1 reference

25 November 2017

1

1 reference

25 November 2017

Lindley C

2

1 reference

25 November 2017

Decker JL

3

1 reference

25 November 2017

Williamson KM

4

1 reference

25 November 2017

Meadowcroft AM

5

1 reference

25 November 2017

Graff D

6

1 reference

25 November 2017

Sawyer WT

7

1 reference

25 November 2017

Blough DK

8

1 reference

25 November 2017

Pieper JA

9

1 reference

25 November 2017

1 July 2001

1 reference

The Journal of Clinical Pharmacology

25 November 2017

1 reference

25 November 2017

41

1 reference

25 November 2017

723-731

1 reference

25 November 2017

7

1 reference

Gender effects in pharmacokinetics and pharmacodynamics

25 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Gender differences in human pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Alterations in prednisolone disposition as a result of oral contraceptive use and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Intersubject and dose-related variability after intravenous administration of erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Effect of age and gender on the activity of human hepatic CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Phenotypic differences in dextromethorphan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Aging and alfentanil disposition in healthy volunteers and surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Effect of age and gender on tirilazad pharmacokinetics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Induction of CYP2D6 in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Antipyrine metabolism during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Menstrual cycle effects on caffeine elimination in the human female

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Impairment of antipyrine metabolism by low-dose oral contraceptive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122010627

10.1177/00912700122010627

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference